References
Assmann G., Smootz E., Adler K., Capurso A., Oette K.: The lipoprotein abnormality in Tangier disease. Quantitation of A apoproteins — J. clin. Invest.59, 565, 1977.
Belfrage P. K. J.: Simple liquid-liquid partition system for isolation of labelled oleic acid from mixtures with glycerides — J. Lipid Res.10, 341, 1969.
Capurso A., Pace L., Resta F., Riso V., Di Monte D., Bonomo L.: Possible role of glycosaminoglycans in reducing the uptake of human lipoproteins by the arterial wall — Pharmacol. Res. Commun.11, 311, 1979.
Castelli W. P.: High density lipoproteins: an overview. In:Gotto A. M. Jr.,Smith L. C., Allen B. (Eds): Atherosclerosis. Springer-Verlag, New York, 1980; vol. V, p. 478.
Catapano A. L., Jackson R. L., Gilliam E. B., Gotto A. M. Jr.,Smith L. C.: Quantification of apo C-II and apo C-III of human very low density lipoproteins by analytical isoelectrofocusing — J. Lipid Res.19, 1047, 1978.
Catapano A. L., Kinnunen P., Packard C., Smith L. C.: Catabolism of human very low density lipoproteins (VLDL) subclasses by lipoprotein lipase (LPL)in vitro. In:Carlson L. A., Paoletti R., Sirtori C. R., Weber G. (Eds): International Conference on Atherosclerosis. Raven Press, New York, 1978; p. 315.
Davis B. J.: Disk electrophoresis. II. Method and application to human serum proteins — Ann. N.Y. Acad. Sci.121, 404, 1964.
Deckelbaum R. J., Olivecrona T., Fainaru M.: The role of different albumin preparations on production of human lipoprotein-like particlesin vitro — J. Lipid Res.21, 425, 1980.
Eisenberg S., Chajek T., Deckelbaum R.: Molecular aspects of lipoprotein interconversion — Pharmacol. Res. Commun.10, 729, 1978.
Ewing A. M., Freeman N. K., Lindcren F. T.: The analysis of human serum lipoprotein distribution. In:Paoletti R., Kritchevsky D. (Eds): Advances in lipid research. Academic Press, New York, 1965; vol. 3, p. 25.
Forte T. M., Krauss R. K., Lindgren F. T., Nichols A. V.: Changes in plasma lipoprotein distribution and formation of two unusual particles after heparin-induced lipolysis in hypertriglyceridemic subjects — Proc. nat. Acad. Sci. (Wash.)76, 5934, 1979.
Fredrickson D. S., Goldstein J. L., Brown M. S.: The familial hyperlipoproteinemias. In:Stanbury J. B., Wyngaarden J. B., Fredrickson D. S. (Eds): The metabolic basis of inherited disease. 4th ed., McGraw-Hill, New York, 1978; p. 604.
Glickman R. M., Green P. H. R.: The intestine as a source of apolipoprotein A-I — Proc. nat. Acad. Sci. (Wash.)74, 729, 1977.
Glomset J. A., Norum K. R.: The metabolic role of lecithin:cholesterol acyltransferase: perspectives from pathology. In:Paoletti R., Kritchevsky D. (Eds): Advances in lipid research. Academic Press, New York, 1973; vol. 11, p. 1.
Gordon T. G., Castelli W. P., Hjörtland M. C., Kannel W. B., Dawber T. R.: High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study — Amer. J. Med.62, 707, 1977.
Green P. H. R., Tall A. R., Glickman R. M.: Rat intestine secretes discoid high density lipoproteins — J. clin. Invest.61, 528, 1978.
Hamilton R. L.: Synthesis and secretion of plasma lipoproteins — Advanc. exp. Med. Biol.26, 7, 1972.
Havel R. J., Kane J. P., Kashyap M. L.: Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipaemia in man — J. clin. Invest.52, 32, 1973.
Hirsch J., Ahrens E. H. Jr.: The separation of complex lipid mixture by the use of silicic acid chromatography — J. biol. Chem.233, 311, 1958.
Hopf U., Assmann G., Schaefer H. E., Capurso A.: Demonstration of human apolipoprotein A in isolated mucosal cells from small intestine and isolated hepatocytes — Gut20, 219, 1979.
Kinnunen P. K. J.: Purification of bovine milk lipoprotein lipase with aid of detergent — Med. Biol.51, 187, 1977.
Kostner G., Holasek A.: Characterization and quantitation of the apolipoproteins from human chyle chylomicrons — Biochemistry11, 1217, 1972.
Laurell C.-B.: Electroimmunoassay — Scand. J. clin. Lab. Invest.29 (Suppl. 124), 21, 1972.
Mills G. L., Chapman M. J., McTaggart F.: Some effects of diet on guinea pig serum lipoproteins — Biochim. biophys. Acta (Amst.)260, 401, 1972.
Nichols A. V., Strisower E. H., Lindgren F. T., Adamson G. L., Caggiola E. L.: Analysis of change in ultracentrifugal lipoprotein profiles following heparin and ethyl-p-chlorophenoxyisobutyrate administration — Clin. chim. Acta20, 277, 1968.
Redgrave T. G., Small D. M.: Quantitation of the transfer of surface phospholipids of chylomicrons to the high density lipoprotein fraction during the catabolism of chylomicrons in rat — J. clin. Invest.64, 162, 1979.
Roheim P. S., Gidez L. I., Eder H. A.: Extrahepatic synthesis of lipoproteins of plasma and chyle. Role of the intestine — J. clin. Invest.45, 297, 1966.
Schaefer E. J., Jenkins L. L., Brewer H. B. Jr.: Human chylomicron apolipoprotein metabolism — Biochem. biophys. Res. Commun.80, 405, 1978.
Weber K., Osborn M.: The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis — J. biol. Chem.244, 4406, 1969.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Capurso, A., Catapano, A.L., Mills, G.L. et al. Formation of high density lipoprotein-like particles from chylomicrons. La Ricerca Clin. Lab. 12, 51–62 (1982). https://doi.org/10.1007/BF02909309
Issue Date:
DOI: https://doi.org/10.1007/BF02909309